期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 18, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/ijms18040697
关键词
ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis; adenosine receptors; inflammation
资金
- University of Ferrara, Italy
Rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are chronic inflammatory rheumatic diseases that affect joints, causing debilitating pain and disability. Adenosine receptors (ARs) play a key role in the mechanism of inflammation, and the activation of A(2A) and A(3)AR subtypes is often associated with a reduction of the inflammatory status. The aim of this study was to investigate the involvement of ARs in patients suffering from early-RA (ERA), RA, AS and PsA. Messenger RNA (mRNA) analysis and saturation binding experiments indicated an upregulation of A(2A) and A(3)ARs in lymphocytes obtained from patients when compared with healthy subjects. A(2A) and A(3)AR agonists inhibited nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) activation and reduced inflammatory cytokines release, such as tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta and IL-6. Moreover, A(2A) and A(3)AR activation mediated a reduction of metalloproteinases (MMP)-1 and MMP-3. The effect of the agonists was abrogated by selective antagonists demonstrating the direct involvement of these receptor subtypes. Taken together, these data confirmed the involvement of ARs in chronic autoimmune rheumatic diseases highlighting the possibility to exploit A(2A) and A(3)ARs as therapeutic targets, with the aim to limit the inflammatory responses usually associated with RA, AS and PsA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据